[Federal Register Volume 84, Number 64 (Wednesday, April 3, 2019)]
[Rules and Regulations]
[Pages 12936-12937]
[FR Doc No: 2019-06486]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 271

[EPA-R04-RCRA-2018-0528; FRL-9991-62-Region 4]

Mississippi: Final Authorization of State Hazardous Waste
Management Program Revisions

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final authorization.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is granting
Mississippi final authorization for changes to its hazardous waste
program under the Resource Conservation and Recovery Act (RCRA). The
Agency published a proposed rule on October 29, 2018, and provided for
public comment. One comment was received in support of authorizing
Mississippi's proposed revisions. This comment can be reviewed in the
docket for this action under Docket ID No. EPA-R04-RCRA-2018-0528. No
further opportunity for comment will be provided.

DATES: This final authorization is effective April 3, 2019.

ADDRESSES: The EPA has established a docket for this action under
Docket ID No. EPA-R04-RCRA-2018-0528. All documents in the docket are
listed on the http://www.regulations.gov website. Although listed in
the index, some information is not publicly available, e.g.,
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Certain other material, such as
copyrighted material, is not placed on the internet and will be
publicly available only in hard copy form. Publicly available docket
materials are available electronically through http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Leah Davis, Materials and Waste
Management Branch, RCR Division, U.S. Environmental Protection Agency,
Atlanta Federal Center, 61 Forsyth Street SW, Atlanta, Georgia 30303-
8960; telephone number:<PHONE_NUMBER>; fax number:<PHONE_NUMBER>;
email address: [email protected].

SUPPLEMENTARY INFORMATION:

A. What changes to Mississippi's hazardous waste program is EPA
authorizing with this action?

    On June 1, 2018, Mississippi submitted a complete program revision
application seeking authorization of changes to its hazardous waste
program in accordance with 40 CFR 271.21. EPA now makes a final
decision that Mississippi's hazardous waste program revisions that are
being authorized are equivalent to, consistent with, and no less
stringent than the Federal program, and therefore satisfy all of the
requirements necessary to qualify for final authorization. For a list
of State rules being authorized with this Final Authorization, please
see the Proposed Rule published in the October 29, 2018 Federal
Register at 83 FR 54304.

B. What is codification and is EPA codifying Mississippi's hazardous
waste program as authorized in this rule?

    Codification is the process of placing citations and references to
the State's statutes and regulations that comprise the State's
authorized hazardous waste program into the Code of Federal
Regulations. EPA does this by adding those citations and references to
the authorized State rules in 40 CFR part 272. EPA is not codifying the
authorization of Mississippi's revisions at this time. However, EPA
reserves the ability to amend 40 CFR part 272, subpart Z, for the
authorization of Mississippi's program changes at a later date.

C. Statutory and Executive Order Reviews

    This final authorization revises Mississippi's authorized hazardous
waste management program pursuant to Section 3006 of RCRA and imposes
no requirements other than those currently imposed by State law. For
further information on how this authorization complies with applicable
executive orders and statutory provisions, please

see the Proposed Rule published in the October 29, 2018 Federal
Register at 83 FR 54304. The Congressional Review Act, 5 U.S.C. 801 et
seq., as added by the Small Business Regulatory Enforcement Fairness
Act of 1996, generally provides that before a rule may take effect, the
agency promulgating the rule must submit a rule report, which includes
a copy of the rule, to each House of the Congress and to the
Comptroller General of the United States. EPA will submit a report
containing this document and other required information to the U.S.
Senate, the U.S. House of Representatives, and the Comptroller General
of the United States prior to publication in the Federal Register. A
major rule cannot take effect until 60 days after it is published in
the Federal Register. This action is not a ``major rule'' as defined by
5 U.S.C. 804(2). This final action will be effective April 3, 2019.

List of Subjects in 40 CFR Part 271

    Environmental protection, Administrative practice and procedure,
Confidential business information, Hazardous waste, Hazardous waste
transportation, Indian lands, Intergovernmental relations, Penalties,
Reporting and recordkeeping requirements.

    Authority:  This action is issued under the authority of
sections 2002(a), 3006, and 7004(b) of the Solid Waste Disposal Act
as amended, 42 U.S.C. 6912(a), 6926, and 6974(b).

    Dated: March 18, 2019.
Mary S. Walker,
Acting Regional Administrator, Region 4.
[FR Doc. 2019-06486 Filed 4-2-19; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 182 (Thursday, September 21, 2017)]
[Notices]
[Pages 44185-44187]
[FR Doc No: 2017-20107]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-5526]

Department of Health and Human Services, Supply Service Center et
al.; Withdrawal of Approval of 27 Abbreviated New Drug Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval
of 27 abbreviated new drug applications (ANDAs) from multiple
applicants. The holders of the applications notified the Agency in
writing that the drug products were no longer marketed and requested
that the approval of the applications be withdrawn.

DATES: Applied Date: October 23, 2017.

FOR FURTHER INFORMATION CONTACT: Trang Tran, Center for Drug Evaluation
and Research, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 75, Rm. 1671, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The holders of the applications listed in
table 1 have informed FDA that these drug products are no longer
marketed and have requested that FDA withdraw approval of the
applications under the process in Sec.  314.150(c) (21 CFR 314.150(c)).
The applicants have also, by their requests, waived their opportunity
for a hearing. Withdrawal of approval of an abbreviated application
under Sec.  314.150(c) is without prejudice to refiling.

                                 Table 1
------------------------------------------------------------------------
       Application No.                Drug                Applicant
------------------------------------------------------------------------
ANDA 061071.................  Tetracycline          Department of Health
                               Hydrochloride (HCl)   and Human Services,
                               Tablets, 250          Supply Service
                               milligrams (mg).      Center, PSC Bldg.
                                                     14 Boiler House
                                                     Rd., Perry Point,
                                                     MD 21902.
ANDA 062279.................  Grifulvin V           Valeant
                               (griseofulvin         Pharmaceuticals
                               microsize) Tablets    North America, LLC,
                               USP,125 mg, 250 mg,   400 Somerset
                               and 500 mg.           Corporate Blvd.,
                                                     Bridgewater, NJ
                                                     08807.
ANDA 062398.................  Cephalexin Capsules,  Department of Health
                               250 mg and 500 mg.    and Human Services,
                                                     Supply Service
                                                     Center, PSC Bldg.
                                                     14 Boiler House
                                                     Rd., Perry Point,
                                                     MD 21902.
ANDA 062756.................  Primaxin (cilastatin  Merck Sharp & Dohme
                               sodium and            Corp., Subsidiary
                               imipenem) for         of Merck & Co.,
                               Injection,            Inc., 1 Merck Dr.,
                               Equivalent to (EQ)    P.O. Box 100,
                               250 mg base/vial;     Whitehouse Station,
                               250 mg/vial and EQ    NJ 08889.
                               500 mg base/vial;
                               500 mg/vial.
ANDA 062814.................  Gentamicin Sulfate    B. Braun Medical
                               in 0.9% Sodium        Inc., 901 Marcon
                               Chloride Injection,   Blvd., Allentown,
                               EQ 0.8 mg base/       PA 18109.
                               milliliter (mL), EQ
                               1.2 mg base/mL, EQ
                               1.4 mg base/mL, EQ
                               1.6 mg base/mL, EQ
                               1.8 mg base/mL, EQ
                               2 mg base/mL, EQ
                               2.4 mg base/mL, EQ
                               40 mg base/100 mL,
                               EQ 60 mg base/100
                               mL, EQ 70 mg base/
                               100 mL, EQ 80 mg
                               base/100 mL, EQ 90
                               mg base/100 mL, EQ
                               100 mg base/100 mL,
                               and EQ 120 mg base/
                               100 mL.
ANDA 063239.................  Rocephin              Hoffmann-La Roche,
                               (ceftriaxone          Inc., c/o Genentech
                               sodium) for           Inc., 1 DNA Way, MS
                               Injection USP, EQ     241B, South San
                               250 mg base/vial,     Francisco, CA
                               EQ 500 mg base/       94080.
                               vial, and EQ 1 gram
                               (g) base/vial.
ANDA 064127.................  Erythromycin Topical  Renaissance Pharma,
                               Solution, 2%.         Inc., 411 South
                                                     State St., Suite E-
                                                     100, Newton, PA
                                                     18940.
ANDA 064146.................  Amikacin Sulfate in   Hospira, Inc.,
                               Sodium Chloride       Subsidiary of
                               0.9% Injection, EQ    Pfizer Inc., 375 N.
                               500 mg base/100 mL.   Field Dr., Lake
                                                     Forest, IL 60045.
ANDA 070598.................  Metoclopramide HCl    Merck Sharp & Dohme
                               Tablets, EQ 10 mg     Corp., Subsidiary
                               base.                 of Merck & Co.,
                                                     Inc.
ANDA 072080.................  Furosemide Injection  Hospira, Inc.,
                               USP, 10 mg/mL.        Subsidiary of
                                                     Pfizer Inc.
ANDA 074601.................  Dipyridamole           Do.
                               Injection, 5 mg/mL.
ANDA 074720.................  Acyclovir Sodium       Do.
                               Injection, EQ 25 mg
                               base/mL.
ANDA 076564.................  Adenosine Injection   Teva Pharmaceuticals
                               USP, 3 mg/mL.         USA, Inc., 425
                                                     Privet Rd.,
                                                     Horsham, PA 19044.
ANDA 078211.................  Quinapril HCl and     Sun Pharmaceutical
                               Hydrochlorothiazide   Industries Ltd., c/
                               Tablets, EQ 10 mg     o Sun
                               base/12.5 mg, EQ 20   Pharmaceutical
                               mg base/12.5 mg,      Industries, Inc., 2
                               and EQ 20 mg base/    Independence Way,
                               25 mg.                Princeton, NJ
                                                     08540.
ANDA 078935.................  Tramadol HCl Tablets  Northstar Healthcare
                               USP, 50 mg.           Holdings, c/o
                                                     Quality Regulatory
                                                     Consultants, 1966
                                                     Anglers Cove, Vero
                                                     Beach, FL 32963.
ANDA 080810.................  Halothane USP,        Halocarbon Products
                               99.99%.               Corp., 1100 Dittman
                                                     Ct., North Augusta,
                                                     SC 29841.
ANDA 085458.................  Dexamethasone         Watson Laboratories,
                               Tablets USP, 0.5 mg.  Inc., Subsidiary of
                                                     Teva
                                                     Pharmaceuticals
                                                     USA, Inc., 425
                                                     Privet Rd.,
                                                     Horsham, PA 19044.
ANDA 085883.................  Acetaminophen and     Actavis Mid Atlantic
                               Codeine Phosphate     LLC, Subsidiary of
                               Oral Suspension       Teva
                               USP, 120 mg/5 mL      Pharmaceuticals
                               and 12 mg/5 mL.       USA, Inc., 425
                                                     Privet Rd.,
                                                     Horsham, PA 19044.
ANDA 085884.................  Cortisone Acetate     Watson Laboratories,
                               Tablets USP, 25 mg.   Inc., Subsidiary of
                                                     Teva
                                                     Pharmaceuticals
                                                     USA, Inc.
ANDA 086179.................  Carisoprodol Tablets   Do.
                               USP, 350 mg.
ANDA 086440.................  Atropine Sulfate and  Catalent Pharma
                               Diphenoxylate HCl     Solutions, Inc.,
                               Capsules, 0.025 mg/   2725 Scherer Dr.
                               2.5 mg.               North, St.
                                                     Petersburg, FL
                                                     33716.
ANDA 087535.................  Methylprednisolone    Organon USA, Inc.,
                               Sodium Succinate      Subsidiary of Merck
                               for Injection USP,    and Co., Inc., 126
                               EQ 500 mg base/vial   E. Lincoln Ave.,
                               and EQ 1 g base/      P.O. Box 2000,
                               vial.                 Rahway, NJ 07065.
ANDA 087711.................  Dexamethasone         Watson Laboratories,
                               Acetate Injectable    Inc., Subsidiary of
                               Suspension USP, EQ    Teva
                               16 mg base/mL.        Pharmaceuticals
                                                     USA, Inc.
ANDA 088346.................  Heparin Lock Flush    Hospira, Inc.
                               Solution USP and
                               0.9% Sodium
                               Chloride Injection
                               USP, 10 USP heparin
                               units/mL and 100
                               USP heparin units/
                               mL.
ANDA 088852.................  Chlorpropamide        Watson Laboratories,
                               Tablets USP, 100 mg.  Inc., Subsidiary of
                                                     Teva
                                                     Pharmaceuticals
                                                     USA, Inc.

ANDA 091201.................  Meropenem for         Sandoz Inc., 100
                               Injection USP, 500    College Rd. West,
                               mg/vial and 1 g/      Princeton, NJ
                               vial.                 08540.
ANDA 200156.................  Armodafinil Tablets,  Watson Laboratories,
                               100 mg and 200 mg.    Inc., Subsidiary of
                                                     Teva
                                                     Pharmaceuticals
                                                     USA, Inc.
------------------------------------------------------------------------

    Therefore, approval of the applications listed in table 1, and all
amendments and supplements thereto, is hereby withdrawn, effective
October 23, 2017. Introduction or delivery for introduction into
interstate commerce of products without approved new drug applications
violates section 301(a) and (d) of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 331(a) and (d)). Drug products that are listed in table
1 that are in inventory on the date that this notice becomes effective
(see the DATES section) may continue to be dispensed until the
inventories have been depleted or the drug products have reached their
expiration dates or otherwise become violative, whichever occurs first.

    Dated: September 15, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-20107 Filed 9-20-17; 8:45 a.m.]
 BILLING CODE 4164-01-P


                  UNITED STATES ENVIRONMENTAL PROTECTION AGENCY                 NATIONAL VEHICLE AND FUEL EMISSIONS LABORATORY                              2000 TRAVERWOOD DRIVE                            ANN ARBOR, MI  48105-2498

									     OFFICE OF 									AIR AND RADIATION May 23, 2023

MEMORANDUM

SUBJECT: Piston-engine Aircraft in Alaska

FROM: Marion Hoyer

TO:  EPA Docket # EPA-HQ-OAR-2022-0389

This memo documents a meeting held on October 27, 2022, between representatives of the Alaska Department of Environmental Conservation (AK DEC) and EPA to discuss the use of piston-engine aircraft in Alaska. The meeting attendees from AK DEC included Jason Olds, Barbara Trost, Nick Czarnecki, and Cindy Heil, and from EPA included Marion Hoyer.

The discussion focused on the importance of piston-engine aircraft in Alaska.

In response to a request from the meeting attendees from AK DEC for information on EPA's National Emissions Inventory for 2017 emissions of lead from piston-engine aircraft in Alaska, both the state total, as well as airport-specific lead, EPA staff provided the file Docket ID EPA-HQ-OAR-2022-0389-0043 that has the landing and take-off data and lead emissions at all the airports in the U.S. EPA staff further explained that for many airports there are two entries; one for general aviation (GA) activity by piston aircraft and one for air taxi (AT) activity by piston aircraft. These are estimates based on the method posted on EPA's website at https://nepis.epa.gov/Exe/ZyPDF.cgi/P1009I13.PDF?Dockey=P1009I13.PDF.

EPA staff further explained that to obtain the amount of lead at each airport during landing and takeoff, one needs to sum the GA and AT lead, and that to obtain the total amount of lead emitted in the state of Alaska from piston-engine aircraft, one would sum the amount of lead emitted at airports and the lead emitted in-flight, outside the landing and takeoff cycle.  EPA staff explained that EPA's estimates of lead emitted in-flight are calculated by allocating the lead emitted in-flight to states based on their share of total national landing and takeoff activity, as explained in the method at https://nepis.epa.gov/Exe/ZyPDF.cgi/P1009I13.PDF?Dockey=P1009I13.PDF.

EPA staff explained that this is because EPA's estimates initially start with a total amount of lead emitted by piston-engine using FAA estimates of the volume of leaded avgas consumed each year. Airport-specific lead is estimated based on the landing and takeoff activity (which is in the spreadsheet at Docket ID EPA-HQ-OAR-2022-0389-0043), but the in-flight lead must be included to be complete.

EPA staff further explained that, using these methods and the information provided, the total amount of in-flight lead estimated to be emitted in Alaska in 2017 is 4.0 tons and the total amount of lead estimated to be emitted in the landing and takeoff cycle is 3.6 tons.

Finally, EPA staff explained that with regard to the airport-specific lead inventories that EPA does not have fuel consumption estimates for the largest piston-engine aircraft used in Alaska (e.g., DC-6, C-46).  As such, the estimates of lead emitted at airports where these aircraft operate are likely to be underestimates.


[Federal Register Volume 88, Number 20 (Tuesday, January 31, 2023)]
[Proposed Rules]
[Pages 6211-6213]
[FR Doc No: 2023-01709]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 117

[Docket No. USCG-2022-0520]
RIN 1625-AA09

Drawbridge Operation Regulation; Mianus River, Greenwich, CT

AGENCY: Coast Guard, DHS.

ACTION: Notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard proposes to modify the operating schedule that
governs the Metro-North (Cos Cob) Bridge, across the Mianus River, mile
1.0, at Greenwich, CT. The bridge owner, Metro-North (MNR), submitted a
request on May 5, 2022 to modify the regulation to align with the
Metro-North ``WALK'' Bridge train schedule and avoid bridge openings
during peak transit hours. It is expected that this change to the
regulations will better serve the needs of the community while
continuing to meet the reasonable needs of navigation. We invite your
comments on this proposed rulemaking.

DATES: Comments and related material must reach the Coast Guard on or
before March 2, 2023.

ADDRESSES:  You may submit comments identified by docket number USCG-
2022-0520 using Federal Decision Making Portal at https://www.regulations.gov.
    See the ``Public Participation and Request for Comments'' portion
of the

SUPPLEMENTARY INFORMATION section below for instructions on submitting
comments.

FOR FURTHER INFORMATION CONTACT: If you have questions on this proposed
rule, call or email Ms. Stephanie E. Lopez, First Coast Guard District,
Project Officer, telephone<PHONE_NUMBER>, email
[email protected].

SUPPLEMENTARY INFORMATION:

I. Table of Abbreviations

CFR Code of Federal Regulations
DHS Department of Homeland Security
FR Federal Register
MNR Metro North
OMB Office of Management and Budget
NPRM Notice of Proposed Rulemaking
Sec.  Section
U.S.C. United States Code

II. Background, Purpose and Legal Basis

    The Metro-North (Cos Cob) Bridge at mile 1.0, across the Mianus
River, Greenwich, CT, has a vertical clearance of 20 feet at mean high
water and a horizontal clearance of approximately 67 feet. Waterway
users include recreational and commercial vessels, including fishing
vessels.
    The existing drawbridge operating regulations are listed at 33 CFR
117.209.
    MNR is requesting the modification of the requirements in 33 CFR
part 117.209 to align with the existing requirements for the Metro-
North ``WALK'' Bridge, across the Norwalk River, at mile 0.1.
    The Cos Cob Bridge is located at one of the busiest rail segments
in the United States and the Northeast Corridor. Openings at Cos Cob
Bridge, between the calendar years of 2019 and 2021, resulted in
seventy-one (71) delays to MNR train service. A delay due to a bridge
opening has cascading affects, resulting in multiple delayed and late
trains. Delays due to the openings of Cos Cob Bridge were notably high
among the drawbridges on MNR service territory. Aligning the Cos Cob
Bridge regulation with the WALK Bridge regulation 33 CFR 117.217(b),
provides a balance between railroad operations and the interest of
waterway users.

III. Discussion of Proposed Rule

    The proposed rule provides the draw to open on signal between 4:30
a.m. and 9 p.m. given at least a two-hour advance notice is given via
marine radio or telephone; except that from 5:45 through 9:45 a.m. and
from 4 through 8 p.m. From 9 p.m. through 4:30 a.m. the draw shall open
on signal after at least a four-hour advance notice is given via marine
radio or telephone. A delay in opening the draw not to exceed 10
minutes may occur when a train scheduled to cross the bridge without
stopping has entered the drawbridge lock. The reason for these changes
is to minimize train delays while balancing the needs of waterway
users.

IV. Regulatory Analyses

    We developed this proposed rule after considering numerous statutes
and Executive orders related to rulemaking. A summary of our analyses
based on these statutes and Executive orders follows.

A. Regulatory Planning and Review

    Executive Orders 12866 and 13563 direct agencies to assess the
costs and benefits of available regulatory alternatives and, if
regulation is necessary, to select regulatory approaches that maximize
net benefits. This NPRM has not been designated a ``significant
regulatory action,'' under Executive Order 12866. Accordingly, the NPRM
has not been reviewed by the Office of Management and Budget (OMB).
    This regulatory action determination is based on the ability of
vessels to still transit the bridge given advanced notice.

B. Impact on Small Entities

    The Regulatory Flexibility Act of 1980 (RFA), 5 U.S.C. 601-612, as
amended, requires Federal agencies to consider the potential impact of
regulations on small entities during rulemaking. The term ``small
entities'' comprises small businesses, not-for-profit organizations
that are independently owned and operated and are not dominant in their
fields, and governmental jurisdictions with populations of less than
50,000. The Coast Guard certifies under 5 U.S.C. 605(b) that this
proposed rule would not have a significant economic impact on a
substantial number of small entities.
    While some owners or operators of vessels intending to transit the
bridge may be small entities, for the reasons stated in section IV.A.
above, this proposed rule would not have a significant economic impact
on any vessel owner or operator.
    If you think that your business, organization, or governmental
jurisdiction qualifies as a small entity and that this rule would have
a significant economic impact on it, please submit a comment (see
ADDRESSES) explaining why you think it qualifies and how and to what
degree this rule would economically affect it.
    Under section 213(a) of the Small Business Regulatory Enforcement
Fairness Act of 1996 (Pub. L. 104-121), we want to assist small
entities in understanding this proposed rule. If the rule would affect
your small business, organization, or governmental jurisdiction and you
have questions concerning its provisions or options for compliance,
please contact the person listed in the FOR FURTHER INFORMATION CONTACT
section. The Coast Guard will not retaliate against small entities that
question or complain about this proposed rule or any policy or action
of the Coast Guard.

C. Collection of Information

    This proposed rule would call for no new collection of information
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520.).

D. Federalism and Indian Tribal Governments

    A rule has implications for federalism under Executive Order 13132
(Federalism), if it has a substantial direct effect on the States, on
the relationship between the National Government and the States, or on
the distribution of power and responsibilities among the various levels
of government. We have analyzed this proposed rule under that order and
have determined that it is consistent with the fundamental federalism
principles and preemption requirements described in Executive Order
13132.
    Also, this proposed rule does not have tribal implications under
Executive Order 13175 (Consultation and Coordination with Indian Tribal
Governments) because it would not have a substantial direct effect on
one or more Indian tribes, on the relationship between the Federal
Government and Indian tribes, or on the distribution of power and
responsibilities between the Federal Government and Indian tribes. If
you believe this proposed rule has implications for federalism or
Indian tribes, please contact the person listed in the FOR FURTHER
INFORMATION CONTACT section.

E. Unfunded Mandates Reform Act

    The Unfunded Mandates Reform Act of 1995 (2 U.S.C. 1531-1538)
requires Federal agencies to assess the effects of their discretionary
regulatory actions. In particular, the Act addresses actions that may
result in the expenditure by a State, local, or tribal government, in
the aggregate, or by the private sector of $100,000,000 (adjusted for
inflation) or more in any one year. Though this proposed rule will not
result in such an expenditure, we do discuss the effects of this
proposed rule elsewhere in this preamble.

F. Environment

    We have analyzed this rule under Department of Homeland Security
Management Directive 023-01, Rev.1, associated implementing
instructions, and Environmental Planning Policy COMDTINST 5090.1
(series), which guide the Coast Guard in complying with the National
Environmental Policy Act of 1969 (NEPA) (42 U.S.C. 4321-4370f). The
Coast Guard has determined that this action is one of a category of
actions that do not individually or cumulatively have a significant
effect on the human environment. This proposed rule promulgates the
operating regulations or procedures for a drawbridge. Normally such
actions are categorically excluded from further review, under paragraph
L49, of Chapter 3, Table 3-1 of the U.S. Coast Guard Environmental
Planning Implementation Procedures.
    Neither a Record of Environmental Consideration nor a Memorandum
for the Record are required for this rule. We seek any comments or
information that may lead to the discovery of a significant
environmental impact from this proposed rule.

G. Protest Activities

    The Coast Guard respects the First Amendment rights of protesters.
Protesters are asked to contact the person listed in the FOR FURTHER
INFORMATION CONTACT section to coordinate protest activities so that
your message can be received without jeopardizing the safety or
security of people, places or vessels.

V. Public Participation and Request for Comments

    We view public participation as essential to effective rulemaking
and will consider all comments and material received during the comment
period. Your comment can help shape the outcome of this rulemaking. If
you submit a comment, please include the docket number for this
rulemaking, indicate the specific section of this document to which
each comment applies, and provide a reason for each suggestion or
recommendation.
    We encourage you to submit comments through the Federal Decision
Making Portal at https://www.regulations.gov. To do so, go to https://www.regulations.gov, type USCG-2022-0520 in the search box and click
``Search.'' Next, look for this document in the Search Results column,
and click on it. Then click on the Comment option. If your material
cannot be submitted using https://www.regulations.gov, contact the
person in the FOR FURTHER INFORMATION CONTACT section of this document
for alternate instructions.
    To view documents mentioned in this proposed rule as being
available in the docket, find the docket as described in the previous
paragraph, and then select ``Supporting & Related Material'' in the
Document Type column. Public comments will also be placed in our online
docket and can be viewed by following instructions on the https://www.regulations.gov Frequently Asked Questions web page. We review all
comments received, but we will only post comments that address the
topic of the proposed rule. We may choose not to post off-topic,
inappropriate, or duplicate comments that we receive. Additionally, if
you go to the online docket and sign up for email alerts, you will be
notified when comments are posted, when a final rule is published, or
of any posting or updates to the docket.
    We accept anonymous comments. Comments we post to https://www.regulations.gov will include any personal information you have
provided. For more about privacy and submissions in response to this
document, see DHS's eRulemaking System of Records notice (85 FR 14226,
March 11, 2020).

List of Subjects in 33 CFR Part 117

    Bridges.

    For the reasons discussed in the preamble, the Coast Guard proposes
to amend 33 CFR part 117 as follows:

PART 117--DRAWBRIDGE OPERATION REGULATIONS

0
1. The authority citation for part 117 continues to read as follows:

    Authority: 33 U.S.C. 499; 33 CFR 1.05-1; and Department of
Homeland Security Delegation No. 0170.1.

0
2. Revise Sec.  117.209 to read as follows:

Sec.  117.209  Mianus River.

    The draw of the Metro-North (Cos Cob) bridge, mile 1.0 at
Greenwich, shall operate as follows:
    (a) From 5 a.m. to 9 p.m.--
    (1) The draw shall open on signal immediately for the passage of
commercial vessels and as soon as practicable but no later than 20
minutes after the signal to open for the passage of all other vessels.
    (2) When a train scheduled to cross the bridge without stopping has
passed the Greenwich or Riverside stations and is in motion toward the
bridge, the draw shall open as soon as the train has crossed the
bridge.
    (b) The draw shall open on signal between 4:30 a.m. and 9 p.m.
after at least a two-hour advance notice is given; except that, from
5:45 a.m. through 9:45 a.m. and from 4 p.m. through 8 p.m., Monday
through Friday excluding holidays, the draw need not open for the
passage of vessel traffic unless an emergency exists.
    (1) From 9 p.m. through 4:30 a.m. the draw shall open on signal
after at least a four-hour advance notice is given.
    (2) A delay in opening the draw not to exceed 10 minutes may occur
when a train scheduled to cross the bridge without stopping has entered
the drawbridge lock.
    (3) Requests for bridge openings may be made by calling the bridge
via marine radio VHF FM Channel 13 or the telephone number posted at
the bridge.

    Dated: January 8, 2023.
J.W. Mauger,
Rear Admiral, U.S. Coast Guard, Commander, First Coast Guard District.
[FR Doc. 2023-01709 Filed 1-30-23; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register: July 19, 2007 (Volume 72, Number 138)]
[Notices]
[Page 39613-39615]
[DOCID:fr19jy07-36]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings  1

July 12, 2007.
    Take notice that the Commission received the following exempt
wholesale generator filings:
    Docket Numbers: EG07-53-000.
    Applicants: Bethlehem Renewable Energy, LLC.
    Description: Bethlehem Renewable Energy, LLC submits a supplement
to its 5/16/07 filing.
    Filed Date: 06/28/2007.
    Accession Number: 20070703-0145.
    Comment Date: 5 p.m. Eastern Time on Thursday, July 19, 2007.

    Docket Numbers: EG07-64-000.
    Applicants: Benton County Wind Farm.
    Description: Benton County Wind Farm submits an Exempt Wholesale
Generator Notice of Self-Certification.
    Filed Date: 07/03/2007.
    Accession Number: 20070703-5009.
    Comment Date: 5 p.m. Eastern Time on Tuesday, July 24, 2007.

    Docket Numbers: EG07-66-000.
    Applicants: Edison Mission Group.
    Description: Edison Mission Group submits a Notice of Self-
Certification of Exempt Wholesale Generator Status.
    Filed Date: 07/09/2007.
    Accession Number: 20070709-5046.

    Comment Date: 5 p.m. Eastern Time on Monday, July 30, 2007.
    Take notice that the Commission received the following electric
rate filings:
    Docket Numbers: ER99-4122-023; ER99-4124-019; ER07-428-001.
    Applicants: Arizona Public Service Company; APS Energy Services
Company; Pinnacle West Marketing & Trading.
    Description: Arizona Public Service Co et al. submits a notice of
change in status of generation capacity.
    Filed Date: 07/02/2007.
    Accession Number: 20070711-0036.
    Comment Date: 5 p.m. Eastern Time on Monday, July 23, 2007.

    Docket Numbers: ER03-1368-004; ER03-1372-005; ER03-1371-004.
    Applicants: Cleco Power LLC; Arcadia Power Partners, LLC; Cleco
Evangeline LLC.
    Description: Cleco Power LLC et al. submits 1st Revised Sheet 4,
Superseding Original Sheet 4 et al. to FERC Electric Tariff, 1st
Revised Volume 2.
    Filed Date: 07/03/2007.
    Accession Number: 20070711-0035.
    Comment Date: 5 p.m. Eastern Time on Tuesday, July 24, 2007.

    Docket Numbers: ER03-1413-005.
    Applicants: Sempra Energy Trading Corp.
    Description: Sempra Energy Trading Corp informs FERC that effective
6/1/07 its energy management agreement with Lake Road Generating
Company, LP was terminated.
    Filed Date: 06/14/2007.
    Accession Number: 20070702-0257.
    Comment Date: 5 p.m. Eastern Time on Monday, July 23, 2007.

    Docket Numbers: ER05-69-003.
    Applicants: NSTAR Electric Company.
    Description: NSTAR Electric Company's request for a two week
extension of time to allow them to make the annual informational
reports filing on 7/14/07.
    Filed Date: 06/28/2007.
    Accession Number: 20070702-0060.
    Comment Date: 5 p.m. Eastern Time on Thursday, July 19, 2007.

    Docket Numbers: ER07-653-002.
    Applicants: The United Illuminating Company.
    Description: The United Illuminating Company submits its clean and
black-lined versions of revisions to Schedule UI-21 of ISO New England
Inc's Open Access Transmission Tariff.
    Filed Date: 07/06/2007.
    Accession Number: 20070709-0137.
    Comment Date: 5 p.m. Eastern Time on Friday, July 27, 2007.

    Docket Numbers: ER07-720-001.
    Applicants: New York Independent System Operator, Inc.
    Description: New York Independent System Operator submits its
compliance filing required by FERC's June Order.
    Filed Date: 07/03/2007.
    Accession Number: 20070706-0053.
    Comment Date: 5 p.m. Eastern Time on Tuesday, July 24, 2007.

    Docket Numbers: ER07-883-002.
    Applicants: Southwest Power Pool, Inc.
    Description: Southwest Power Pool, Inc submits an executed Service
Agreement for Network Integration Transmission Service with Kansas City
Power & Light Company.
    Filed Date: 06/29/2007.
    Accession Number: 20070703-0113.
    Comment Date: 5 p.m. Eastern Time on Friday, July 20, 2007.

    Docket Numbers: ER07-924-001.
    Applicants: Kansas City Power & Light Company.
    Description: Kansas City Power & Light submits substitute sheets to
replace the corresponding sheets that were originally filed on 5/22/07.
    Filed Date: 07/05/2007.
    Accession Number: 20070709-0118.
    Comment Date: 5 p.m. Eastern Time on Thursday, July 26, 2007.

    Docket Numbers: ER07-984-001.
    Applicants: Entergy Gulf States, Inc.
    Description: Entergy Gulf States Inc submits an executed version of
an amended and conformed Power Sales Agreement for the Toledo Bend
Project with Sabine River Authority.
    Filed Date: 07/06/2007.
    Accession Number: 20070709-0142.
    Comment Date: 5 p.m. Eastern Time on Friday, July 27, 2007.

    Docket Numbers: ER07-1065-001.
    Applicants: Public Service Company of New Mexico.
    Description: City of Farmington, New Mexico submits a certificate
of Concurrence re the filing by Public Service Co of New Mexico on 6/
21/07.
    Filed Date: 07/09/2007.
    Accession Number: 20070711-0034.
    Comment Date: 5 p.m. Eastern Time on Monday, July 30, 2007.

    Docket Numbers: ER07-1090-001.
    Applicants: PJM Interconnection L.L.C.
    Description: PJM Interconnection, L.L.C. submits a corrected
version of its Wholesale Market Participation Agreement.
    Filed Date: 07/10/2007.
    Accession Number: 20070711-0033.
    Comment Date: 5 p.m. Eastern Time on Tuesday, July 31, 2007.

    Docket Numbers: ER07-1100-000.
    Applicants: Entergy Services, Inc.
    Description: Entergy Services Inc submits its Second Revised
Network Integration Transmission Service Agreement and First Revised
Network Operating Agreement.
    Filed Date: 06/29/2007.
    Accession Number: 20070702-0061.
    Comment Date: 5 p.m. Eastern Time on Friday, July 20, 2007.

    Docket Numbers: ER07-1100-001.
    Applicants: Entergy Services, Inc.
    Description: Entergy Services, Inc. submits an erratum to the
Second Revised Network Integration Transmission Service Agreement with
the City of North Little Rock, Arkansas.
    Filed Date: 07/05/2007.
    Accession Number: 20070709-0117.
    Comment Date: 5 p.m. Eastern Time on Friday, July 20, 2007.

    Docket Numbers: ER07-1134-000.
    Applicants: Old Dominion Electric Cooperative, Inc.
    Description: Old Dominion Electric Cooperative submits an
application for approval of a cost-of-service rate formula to recover
its revenue requirement for certain transmission facilities located in
the Commonwealth of Virginia.
    Filed Date: 07/05/2007.
    Accession Number: 20070709-0116.
    Comment Date: 5 p.m. Eastern Time on Thursday, July 26, 2007.

    Docket Numbers: ER07-1135-000.
    Applicants: Entergy Services, Inc.
    Description: Entergy Services Inc. agent for the Entergy Operating
Companies et al. submits a mutually executed Dynamic Transfer Operating
Agreement with EIS, NLR, and Benton.
    Filed Date: 07/06/2007.
    Accession Number: 20070709-0141.
    Comment Date: 5 p.m. Eastern Time on Friday, July 27, 2007.

    Docket Numbers: ER07-1136-000.
    Applicants: Camp Grove Wind Farm LLC.
    Description: Camp Grove Wind Farm, LLC submits its proposed market-
based rate tariff, entitled FERC Electric Tariff 1 for its wind powered
electric generating facility located in Marshall and Stark Counties,
IL.
    Filed Date: 07/06/2007.
    Accession Number: 20070709-0140.
    Comment Date: 5 p.m. Eastern Time on Friday, July 27, 2007.

    Docket Numbers: ER07-1137-000.
    Applicants: Lockhart Power Company.
    Description: Lockhart Power Company requests FERC's authorization
to make wholesale sales of energy, capacity, and ancillary services at
negotiated, market-based rates pursuant to Wholesale Market-Based Rate
Tariff.

    Filed Date: 07/06/2007.
    Accession Number: 20070709-0139.
    Comment Date: 5 p.m. Eastern Time on Friday, July 27, 2007.

    Docket Numbers: ER07-1138-000.
    Applicants: Jeffers Wind 20, LLC.
    Description: Petition of Jeffers Wind 20, LLC for order accepting
market-based rate tariff for filing and granting waivers and blanket
approvals and request for expedited action.
    Filed Date: 07/09/2007.
    Accession Number: 20070711-0032.
    Comment Date: 5 p.m. Eastern Time on Monday, July 30, 2007.

    Docket Numbers: ER07-1139-000.
    Applicants: York Haven Holdings, Inc.
    Description: York Haven Holdings, Inc. submits a Petition for
market-based rate authority under Section 205 of the Federal Power Act,
and request for waivers and blanket approvals.
    Filed Date: 07/09/2007.
    Accession Number: 20070711-0031.
    Comment Date: 5 p.m. Eastern Time on Monday, July 30, 2007.

    Docket Numbers: ER07-1140-000.
    Applicants: New York Independent System Operator, Inc.
    Description: New York Independent System Operator, Inc., submits
revised tariff sheets for its Market Administration and Control Area
Services Tariff pursuant to Section 205 of the Federal Power Act.
    Filed Date: 07/09/2007.
    Accession Number: 20070711-0037.
    Comment Date: 5 p.m. Eastern Time on Monday, July 30, 2007.
    Take notice that the Commission received the following electric
securities filings:
    Docket Numbers: ES07-43-000: ES07-44-000; ES07-45-000.
    Applicants: PSEG Fossil LLC; PSEG Nuclear LLC; PSEG Energy
Resources & Trade LLC.
    Description: PSEG Companies submit an application for continued
authorization to have outstanding up to $2 billion of short-term
unsecured debt.
    Filed Date: 07/09/2007.
    Accession Number: 20070710-0040.
    Comment Date: 5 p.m. Eastern Time on Monday, July 30, 2007.
    Take notice that the Commission received the following electric
reliability filings:
    Docket Numbers: RR07-11-001.
    Applicants: North American Electric Reliability Corp.
    Description: Compliance Filing of the North American Electric
Reliability Corp., in Response to Paragraph 108 of Order Approving
Regional Reliability Standards for the Western Interconnection and
Directing Modifications.
    Filed Date: 07/09/2007.
    Accession Number: 20070709-5076.
    Comment Date: 5 p.m. Eastern Time on Wednesday, August 8, 2007.
    Any person desiring to intervene or to protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Rules of Practice and Procedure (18 CFR 385.211 and
385.214) on or before 5 p.m. Eastern time on the specified comment
date. It is not necessary to separately intervene again in a subdocket
related to a compliance filing if you have previously intervened in the
same docket. Protests will be considered by the Commission in
determining the appropriate action to be taken, but will not serve to
make protestants parties to the proceeding. Anyone filing a motion to
intervene or protest must serve a copy of that document on the
Applicant. In reference to filings initiating a new proceeding,
interventions or protests submitted on or before the comment deadline
need not be served on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at: http://www.ferc.gov.
 To facilitate electronic service, persons with Internet

access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First St., NE., Washington, DC 20426.
    The filings in the above proceedings are accessible in the
Commission's eLibrary system by clicking on the appropriate link in the
above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive e-mail notification
when a document is added to a subscribed dockets(s). For assistance
with any FERC Online service, please e-mail<EMAIL_ADDRESS>
or call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-13975 Filed 7-18-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 80, Number 46 (Tuesday, March 10, 2015)]
[Notices]
[Pages 12687-12689]
[FR Doc No: 2015-05496]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-74440; File No. SR-NYSEMKT-2014-116]

Self-Regulatory Organizations; NYSE MKT LLC; Order Granting
Approval of a Proposed Rule Change, as Modified by Amendment No. 1, To
Amend Rule 967NY and To Adopt Rule 967.1NY To Provide Price Protection
for Market Maker Quotes

March 4, 2015.

I. Introduction

    On December 29, 2014, NYSE MKT LLC (``Exchange'') filed with the
Securities and Exchange Commission (``Commission''), pursuant to
section 19(b)(1) of the Securities Exchange Act of 1934 (``Act'') \1\
and Rule 19b-4 thereunder,\2\ a proposed rule change to amend Exchange
Rule 967NY (Price Protection) and to adopt Exchange Rule 967.1NY to
provide price protection for Market Maker quotes. The proposed rule
change was published for comment in the Federal Register on January 14,
2015.\3\ The Commission received no comment letters on the proposal. On
March 2, 2015, the Exchange filed Amendment No. 1 to the proposed rule
change.\4\ This order approves the proposed rule change, as modified by
Amendment No. 1 thereto.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Securities Exchange Act Release No. 74017 (January 8,
2015), 80 FR 1979 (``Notice'').
    \4\ In Amendment No. 1, the Exchange clarified that it believes
that Market Maker bids should not be priced the same as or higher
than the corresponding benchmark, which would be the price of the
underlying security for call options and the strike price for put
options. Amendment No. 1 does not change any of the proposed rule
text that was submitted in the original filing. Amendment No. 1 is
technical in nature and, therefore, the Commission is not publishing
it for comment.
---------------------------------------------------------------------------

II. Description of the Proposal

    The Exchange proposed to amend Exchange Rule 967NY and to adopt
Exchange Rule 967.1NY to provide price protection for Market Maker
quotes. Exchange Rule 967NY currently applies

and will continue to apply solely to orders. Exchange Rule 967NY(b),
provides a price protection filter for incoming limit orders, pursuant
to which the Exchange rejects limit orders priced a specified
percentage \5\ through the National Best Bid (``NBB'') or National Best
Offer (``NBO'') (``Limit Order Filter''). To clarify that Exchange Rule
967NY applies only to orders, the Exchange proposed to append the word
``Orders'' to the Exchange Rule 967NY header to provide ``Rule 967NY.
Price Protection--Orders.''\6\
---------------------------------------------------------------------------

    \5\ Pursuant to Exchange Rule 967NY(b), unless determined
otherwise by the Exchange and announced to ATP Holders via Trader
Update, the specified percentage is 100% for the contra-side NBB or
NBO priced at or below $1.00 and 50% for contra-side NBB or NBO
priced above $1.00. See Notice, supra note 3, at 1979.
    \6\ See Notice, supra note 3, at 1979.
---------------------------------------------------------------------------

A. Proposed Market Maker Quote Price Protection

    The Exchange proposed to adopt new Exchange Rule 967.1NY to provide
for a price protection mechanism for quotes entered by a Market Maker.
Exchange Rule 967.1NY(a) will provide price protection filters
applicable only for quotes entered by a Market Maker pursuant to Rule
925.1NY and will not be applicable to orders entered by a Market Maker.
The Exchange proposed to provide for two layers of price protection
that will be applicable to all incoming Market Maker quotes.\7\ The
first layer of price protection will assess incoming sell quotes
against the NBB and incoming buy quotes against the NBO.\8\ The second
layer of price protection will assess the price of call or put bids
against a specified benchmark.
---------------------------------------------------------------------------

    \7\ The Exchange states that the proposal will assist with the
maintenance of fair and orderly markets by averting the risk of
Market Maker quotes sweeping through multiple price points resulting
in executions at prices that are through the last sale price or
National Best Bid or Best Offer (``NBBO''). See Notice, supra note
3, at 1979.
    \8\ The Exchange represents that this proposed price protection
mechanism is similar to the Exchange's Limit Order Filter. See
Notice, supra note 3, at 1979.
---------------------------------------------------------------------------

1. NBBO Price Reasonability Check
    Proposed Exchange Rule 967.1NY(a)(1) sets forth the Exchange's
proposed NBBO price reasonability check, which will compare Market
Maker bids with the NBO and Market Maker offers with the NBB.
Specifically, provided that an NBBO is available, a Market Maker quote
will be rejected if it is priced a specified dollar amount or
percentage through the contra-side NBBO as follows:
    (A) $1.00 for Market Maker bids when the contra-side NBO is priced
at or below $1.00; or
    (B) 50% for Market Maker bids (offers) when the contra-side NBO
(NBB) is priced above $1.00.
    The Exchange will reject inbound Market Maker quotes that exceed
the parameters set forth in proposed Exchange Rule 967.1NY(a)(1)(A)-
(B).\9\ The Exchange states that it has proposed a specific dollar
threshold for when the NBO is priced at or below $1.00 because, for
such low-priced NBOs, the Exchange believes it is appropriate to
provide Market Makers with the ability to enter quotes at least $1.00
higher than the prevailing NBO.\10\ For example, if the NBO were $0.06,
when using a 100% filter, the Exchange would be required to reject any
bids priced $0.12 or more. In addition, the Exchange proposed that
pursuant to proposed Exchange Rule 967.1NY(a)(1)(A), Market Maker
offers that arrive when the NBB is priced at or below $1.00 will not be
subject to this filter. The Exchange notes that when the NBB is priced
at or below $1.00, the price of an offer will be bound by $0.00, and
therefore an offer will always be less than $1.00 away from the
NBB.\11\
---------------------------------------------------------------------------

    \9\ The Exchange states that the proposed percentages are
appropriate because they are based on the percentages established
for the Limit Order Filter. See Notice, supra note 3, at 1979.
    \10\ See Notice, supra note 3, at 1979.
    \11\ The Exchange states that such offer prices would likely not
be erroneous and therefore the Exchange does not believe it
necessary to reject such Market Maker offers. See Notice, supra note
3, at 1980.
---------------------------------------------------------------------------

    Because there may be market scenarios that require the proposed
parameters to be adjusted, for example, during periods of extreme price
volatility, the Exchange has further proposed that the Exchange may
revise these parameters, provided such revised parameters are announced
to ATP Holders via a Trader Update.\12\
---------------------------------------------------------------------------

    \12\ See proposed Exchange Rule 967.1NY(a)(1)(A)-(B) (setting
forth the specified dollar amount or percentages ``unless determined
otherwise by the Exchange and announced to ATP Holders via Trader
Update'').
---------------------------------------------------------------------------

    The Exchange also proposed that if a Market Maker quote is rejected
pursuant to paragraph (a)(1) of the proposed rule, the Exchange will
also cancel any resting same-side quote in the affected series from
that Market Maker.\13\ According to the Exchange, even if the new quote
is rejected because it is priced a specified dollar amount or
percentage through the contra-side NBBO, in violation of proposed
Exchange Rule 967.1NY(a)(1), the Market Maker's implicit instruction to
cancel the resting quote remains valid nonetheless.\14\
---------------------------------------------------------------------------

    \13\ See proposed Exchange Rule 967.1NY(b). The Exchange states
that it believes it is appropriate to reject any resting same-side
quote because when a Market Maker submits a new quote, that Market
Maker is implicitly instructing the Exchange to cancel any resting
quote in that same series. See Notice, supra note 3, at 1980.
    \14\ See Notice, supra note 3, at 1980 for examples illustrating
how proposed Exchange Rule 967.1NY(a) will operate.
---------------------------------------------------------------------------

2. Underlying Stock Price/Strike Price Check
    The Exchange also has proposed new Exchange Rule 967.1NY(a)(2) and
(3) which will set forth the Exchange's proposed second layer of price
protection filters for Market Maker quotes. These price protection
mechanisms will be applicable when either there is no NBBO available,
for example, during pre-opening or prior to conducting a re-opening
after a trading halt, or if the NBBO is so wide as to not to reflect an
appropriate price for the respective options series. Proposed Exchange
Rule 967.1NY(a)(2) will also provide price protection for Market Maker
bids in call options. As proposed, if such bids equal or exceed the
price of the underlying security, the Market Maker bid will be
rejected.\15\
---------------------------------------------------------------------------

    \15\ See proposed Exchange Rule 967.1NY(a)(2). With a call bid,
a Market Maker is bidding to buy an option that would be exercised
into the right to acquire the underlying security. The Exchange
states that it does not believe that a derivative product, which
conveys the right to purchase a security underlying the derivative,
should ever be priced the same as or higher than the prevailing
price of the underlying security itself. Accordingly, the Exchange
believes it is appropriate to reject Market Maker bids for call
options that are equal to or in excess of the price of the
underlying security. See Notice, supra note 3, at 1980. See also
Amendment No. 1, supra note 4.
---------------------------------------------------------------------------

    Under new Exchange Rule 967.1NY(a)(2)(A), before the underlying
security is open, the Exchange will use the previous day's closing
price to determine the price of the underlying security.\16\ Under new
Exchange Rule 967.1NY(a)(2)(B), once the underlying security has
opened, the Exchange will use the consolidated last sale price to
determine the price of the underlying security. Under new Exchange Rule
967.1NY(a)(2)(C), during a trading halt of the underlying security, the
Exchange will use the consolidated last sale reported immediately prior
to the trading halt to determine the price of the underlying
security.\17\ New Exchange

Rule 967.1NY(a)(3) will provide for price protection for Market Maker
bids in put options. In particular, any Market Maker bid for put
options will be rejected if the price of the bid is equal to or greater
than the strike price of the option.\18\
---------------------------------------------------------------------------

    \16\ According to the Exchange, although the underlying
securities may trade in the equities markets outside of 9:30 a.m. ET
to 4:00 p.m. ET, the equities market is generally not as liquid
during this time and equity market makers generally do not have
quoting obligations in after-hours trading. Therefore, the Exchange
believes that using the previous day's closing price--based on
trading during Core Trading Hours, when the market is most liquid--
provides a more accurate benchmark and thus a more precise price
protection filter for underlying securities that have not yet
opened. See Notice, supra note 3, at 1980.
    \17\ The Exchange believes that the consolidated last sale price
for an underlying security that has already opened will provide the
most accurate benchmark because the market is most liquid during
Core Trading Hours. See Notice, supra note 3, at 1981.
    \18\ The Exchange states that the value of a put can never
exceed the strike price of the option, even if the stock goes to
zero. For example, a put with a strike price of $50 gives the holder
the right to sell the underlying security for $50 (no more, or no
less), therefore the Exchange states that it would be illogical to
pay $50 or more for the right to sell that underlying security, no
matter what the price of the underlying security. See Notice, supra
note 3, at 1981. See also Amendment No. 1, supra note 4.
---------------------------------------------------------------------------

    The Exchange also has proposed that when a Market Maker quote is
rejected pursuant to paragraph (a)(2) or (a)(3) of the proposed rule,
the Exchange will also cancel all resting quote(s) in the affected
class(es) from that Market Maker and will not accept new quote(s) in
the affected class(es) until the Market Maker submits a message (which
may be automated) to the Exchange to enable the entry of new
quotes.\19\
---------------------------------------------------------------------------

    \19\ See proposed Exchange Rule 967.1NY(b). The Exchange
believes that this temporary suspension from quoting in the affected
option class(es) would operate as a safety valve that forces Market
Makers to re-evaluate their positions before requesting to re-enter
the market. See Notice, supra note 3, at 1981. See also Notice,
supra note 3, at 1981 for examples illustrating how proposed
Exchange Rule 967.1NY(a)(2) and (a)(3) would operate.
---------------------------------------------------------------------------

B. Implementation

    The Exchange stated that it would announce the implementation date
of the proposed rule change in a Trader Update and publish such
announcement at least 30 days prior to implementation.

III. Discussion and Commission Findings

    After careful review, the Commission finds that the proposed rule
change is consistent with the requirements of the Act and the rules and
regulations thereunder applicable to a national securities exchange
and, in particular, with section 6(b) of the Act.\20\ In particular,
the Commission finds that the proposed rule change is consistent with
sections 6(b)(5) of the Act,\21\ which requires, among other things,
that the rules of a national securities exchange be designed to prevent
fraudulent and manipulative acts and practices, to promote just and
equitable principles of trade, to foster cooperation and coordination
with persons engaged in regulating, clearing, settling, processing
information with respect to, and facilitating transactions in
securities, to remove impediments to and perfect the mechanism of a
free and open market and a national market system, and, in general, to
protect investors and the public interest.
---------------------------------------------------------------------------

    \20\ 15 U.S.C. 78f(b). In approving this proposed rule change,
the Commission has considered the proposed rule's impact on
efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
    \21\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    The proposed rule change provides a price protection mechanism for
quotes entered by a Market Maker when an NBBO is available that are
priced a specified dollar amount or percentage through the last sale or
prevailing contra-side market, which the Exchange believes is evidence
of error. The Commission believes that the proposed price protection
mechanism is reasonably designed to promote just and equitable
principles of trade by preventing potential price dislocation that
could result from erroneous Market Maker quotes sweeping through
multiple price points resulting in executions at prices that are
through the last sale price or NBBO.\22\
---------------------------------------------------------------------------

    \22\ See Notice, supra note 3, at 1981.
---------------------------------------------------------------------------

    The Exchange's proposed use of benchmarks to check the
reasonability of Market Maker bids for call and put options affords a
second layer of price protection to Market Maker quotes. The Commission
believes that the additional price reasonability check on Market Maker
bids that are priced equal to or greater than the price of the
underlying security for call options, and equal to or greater than the
strike price for put options, is reasonably designed to operate in
manner that would remove impediments to and perfect the mechanism of a
free and open market and protect investors and the public interest.
Further, the Commission notes the Exchange's belief that the additional
risk controls that result in the cancellation of a Market Maker's
resting same side quote and/or the temporary suspension a Market
Maker's quoting activity in the affected option class(es), as
applicable, provide market participants with additional protection from
anomalous executions.\23\
---------------------------------------------------------------------------

    \23\ See Notice, supra note 3, at 1982.
---------------------------------------------------------------------------

    Accordingly, the Commission believes that the proposed price
protection for Market Maker quotes is reasonably designed to prevent
fraudulent and manipulative acts and practices, to promote just and
equitable principles of trade, to foster cooperation and coordination
with persons engaged in regulating, clearing, settling, processing
information with respect to, and facilitating transactions in
securities, to remove impediments to and perfect the mechanism of a
free and open market and a national market system, and, in general, to
protect investors and the public interest.

IV. Conclusion

    For the foregoing reasons, the Commission finds that the proposed
rule change is consistent with the Act and the rules and regulations
thereunder applicable to a national securities exchange.
    It is therefore ordered, pursuant to section 19(b)(2) of the
Act,\24\ that the proposed rule change (SR-NYSEMKT-2014-116), as
modified by Amendment No. 1, be, and hereby is, approved.
---------------------------------------------------------------------------

    \24\ 15 U.S.C. 78s(b)(2).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\25\
---------------------------------------------------------------------------

    \25\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-05496 Filed 3-9-15; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 73 (Friday, April 15, 2016)]
[Notices]
[Pages 22364-22365]
[FR Doc No: 2016-08746]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Office of Commercial Space Transportation; Notice of Availability
of the Final Environmental Assessment (Final EA), Finding of No
Significant Impact (FONSI)/Record of Decision (ROD) for the Kodiak
Launch Complex Launch Pad 3, Kodiak Island, Alaska

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation (DOT).

ACTION: Notice of availability of the Final EA and FONSI/ROD.

-----------------------------------------------------------------------

SUMMARY: In accordance with the National Environmental Policy Act of
1969, as amended (NEPA; 42 United States Code 4321 et seq.), Council on
Environmental Quality NEPA implementing regulations (40 CFR parts 1500
to 1508), and FAA Order 1050.1E, Change 1, Environmental Impacts:
Policies and Procedures, the FAA is announcing the availability of the
Final EA and FONSI/ROD for the Kodiak Launch Complex Launch Pad 3.

FOR FURTHER INFORMATION CONTACT: Ms. Stacey M. Zee, Office of
Commercial Space Transportation, Federal Aviation Administration, 800
Independence Ave. SW., Suite 325, Washington DC 20591; email
<EMAIL_ADDRESS>telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The Final EA was prepared to analyze the
potential environmental impacts of the FAA modifying the Alaska
Aerospace Corporation's (AAC's) Launch Site Operator License to include
medium-lift launch capability at the Kodiak Launch Complex (KLC), a
commercial launch site currently operated under a FAA Launch Site
Operator License (LSO-03-008), which authorizes only small-lift
operations. The Kodiak Launch Complex was renamed as Pacific Spaceport
Complex Alaska, effective April 21, 2015. The EA keeps the name as KLC
for continuity and ease of reviewing.
    Expansion of launch capabilities at KLC would include the addition
of new infrastructure necessary to support

medium-lift launches, including the construction of a launch pad and
associated facilities. As part of the Proposed Action addressed in the
EA, AAC would make improvements to the KLC to add both solid and
liquid-propellant, medium-lift launch capability, and to operate the
KLC in the future as a small-lift and medium-lift launch complex.
Proposed construction at KLC includes six primary modifications:
Construction of Launch Pad 3 (LP3), a vehicle processing facility,
rocket staging facility, liquid fuel facility, mission control center
and improvements to Pasagshak Point Road. Proposed launch operations
would include up to six orbital small-lift launches and three medium-
lift launches per year from the existing launch pads and from the
proposed LP3; however, to be conservative in the analysis of potential
environmental impacts, the EA assumes a maximum of nine medium-lift
launches per year.
    The EA addresses the potential environmental impacts of
implementing the Proposed Action and the No Action Alternative. Under
the No Action Alternative, the FAA would not modify AAC's Launch Site
Operator License to include medium-lift launch capability and AAC would
not proceed with the construction of medium-lift launch support
infrastructure at KLC. Existing launch activities for up to nine
orbital small-lift class launches per year from the existing launch
pads would continue.
    The impact categories considered in the EA include air quality;
compatible land use; Department of Transportation Act: Section 4(f);
fish, wildlife, and plants; hazardous materials, pollution prevention,
and solid waste; historical, architectural, archaeological, and
cultural resources; light emissions and visual impacts; natural
resources and energy supply; noise; socioeconomic, environmental
justice, and children's environmental health and safety risk; water
quality; and wetlands. The EA also considers potential cumulative
environmental impacts.
    The FAA has posted the Final EA and FONSI/ROD on the FAA Office of
Commercial Space Transportation Web site: http://www.faa.gov/about/office_org/headquarters_offices/ast/environmental/nepa_docs/review/operator/.
    The FAA published a Notice of Availability (NOA) of the Draft EA in
the Federal Register on September 15, 2014. An electronic version was
also made available on the FAA Web site. In addition, the FAA printed
and mailed a copy of the Draft EA to local libraries. The FAA held an
open house public meeting on October 7, 2014. The public comment period
for the Draft EA ended on November 1, 2014. After taking into
consideration the nature of public comments received on the Draft EA,
the FAA issued a Second Draft EA and provided the public with an
opportunity to review and comment on updates and clarification
information that had since been added to the EA in response to public
comments. The FAA published a NOA of the Second Draft EA in the Federal
Register on December 7, 2015. Interested parties were invited to submit
comments on the Second Draft EA by January 11, 2016. Public comments on
the Second Draft EA resulted in minor changes to the EA.

    Issued in Washington, DC, on April 11, 2016.
Daniel Murray,
Manager, Space Transportation Development Division.
[FR Doc. 2016-08746 Filed 4-14-16; 8:45 am]
 BILLING CODE 4310-13-P


"King, Heidi R."<EMAIL_ADDRESS> 03/04/2008 07:37 PM

To

Bruce Schillo/DC/USEPA/US@EPA, "Johansson, Robert" <EMAIL_ADDRESS>"Fraas, Arthur G." <EMAIL_ADDRESS> cc

Brian Mannix/DC/USEPA/US@EPA, Alexander Cristofaro/DC/USEPA/US@EPA, Al McGartland/DC/USEPA/US@EPA, Lesley Schaaff/DC/USEPA/US@EPA, Eileen Pritchard/DC/USEPA/US@EPA, Janet Cakir/RTP/USEPA/US@EPA, Ron Evans/RTP/USEPA/US@EPA

Subject

RE: Ozone NAAQS RIA appendix A to chapter 9

Good evening Bruce,

To make sure we're working from the correct documents in review of the Ozone NAAQS Regulatory Impact Analysis, please find below a list of the files I have received as of this evening, including those files attached to your email of 6:04 pm today.

Note that

- I exclude from this list the draft of chapter 9 which you replaced with the file "9-OzoneRIAChapter9rev".

- There is not a chapter 7 appendix b (should I have received a file by that name?)

Please let me know if there are additional files that I should have received, or whether I've included in this list versions that should have been replaced.

With warmest regards,

heidi

(202) 395-4551

TableOfContents

0-OzoneRIAexecsum

1-OzoneRIAchapter1

2-OzoneRIAchapter2

2-OzoneRIAchapter2appendix

3-OzoneRIAchapter3

3-OzoneRIAchapter3appendix

4-OzoneRIAchapter4

5-OzoneRIAchapter5

5-OzoneRIAchapter5appendix

6-OzoneRIAchapter6

6-OzoneRIAchapter6_appendix

7-OzoneRIAChapter omb

7-OzoneRIAChapter7appendixa

7-OzoneRIAChapter7appendixc

8-OzoneRIAChapter8

9-OzoneRIAChapter9rev

9-OzoneRIAChapter9appendixA

10-OzoneRIAChapter10

From<EMAIL_ADDRESS><EMAIL_ADDRESS> Sent: Tuesday, March 04, 2008 6:04 PM

To: King, Heidi R.; Johansson, Robert; Fraas, Arthur G.

Cc<EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS> Subject: Ozone NAAQS RIA appendix A to chapter 9

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Bruce Schillo

Regulatory Analysis & Policy Division

Office of Policy, Economics, and Innovation

U.S. EPA

1200 Pennsylvania Avenue, NW

Mail Code 1803, AR-3512-a

Washington, DC  20460

202-564-6552

202-564-7322 (fax)

<EMAIL_ADDRESS>


[Federal Register Volume 86, Number 148 (Thursday, August 5, 2021)]
[Notices]
[Page 42843]
[FR Doc No: 2021-16692]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2021-P-0271]

Determination That VOTRIENT (Pazopanib Hydrochloride) Tablets,
400 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or
Effectiveness

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) has
determined that VOTRIENT (pazopanib hydrochloride) tablets, 400
milligrams (mg), were not withdrawn from sale for reasons of safety or
effectiveness. This determination will allow FDA to approve abbreviated
new drug applications (ANDAs) for pazopanib hydrochloride tablets, 400
mg, if all other legal and regulatory requirements are met.

FOR FURTHER INFORMATION CONTACT: Sungjoon Chi, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6212, Silver Spring, MD 20993-0002, 240-
402-9674<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In 1984, Congress enacted the Drug Price
Competition and Patent Term Restoration Act of 1984 (Pub. L. 98-417)
(the 1984 amendments), which authorized the approval of duplicate
versions of drug products under an ANDA procedure. ANDA applicants
must, with certain exceptions, show that the drug for which they are
seeking approval contains the same active ingredient in the same
strength and dosage form as the ``listed drug,'' which is a version of
the drug that was previously approved. ANDA applicants do not have to
repeat the extensive clinical testing otherwise necessary to gain
approval of a new drug application (NDA).
    The 1984 amendments include what is now section 505(j)(7) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(7)), which
requires FDA to publish a list of all approved drugs. FDA publishes
this list as part of the ``Approved Drug Products With Therapeutic
Equivalence Evaluations,'' which is known generally as the ``Orange
Book.'' Under FDA regulations, drugs are removed from the list if the
Agency withdraws or suspends approval of the drug's NDA or ANDA for
reasons of safety or effectiveness or if FDA determines that the listed
drug was withdrawn from sale for reasons of safety or effectiveness (21
CFR 314.162).
    A person may petition the Agency to determine, or the Agency may
determine on its own initiative, whether a listed drug was withdrawn
from sale for reasons of safety or effectiveness. This determination
may be made at any time after the drug has been withdrawn from sale,
but must be made prior to approving an ANDA that refers to the listed
drug (Sec.  314.161 (21 CFR 314.161)). FDA may not approve an ANDA that
does not refer to a listed drug.
    VOTRIENT (pazopanib hydrochloride) tablets, 400 mg, are the subject
of NDA 022465, held by Novartis Pharmaceuticals Corp., and initially
approved on October 19, 2009. VOTRIENT is a kinase inhibitor indicated
for the treatment of patients with advanced renal cell carcinoma.
VOTRIENT (pazopanib hydrochloride) tablets, 400 mg, are currently
listed in the ``Discontinued Drug Product List'' section of the Orange
Book.
    Hyman, Phelps & McNamara, P.C., submitted a citizen petition dated
March 5, 2021 (Docket No. FDA-2021-P-0271), under 21 CFR 10.30,
requesting that the Agency determine whether VOTRIENT (pazopanib
hydrochloride) tablets, 400 mg, were withdrawn from sale for reasons of
safety or effectiveness.
    After considering the citizen petition and reviewing Agency records
and based on the information we have at this time, FDA has determined
under Sec.  314.161 that VOTRIENT (pazopanib hydrochloride) tablets,
400 mg, were not withdrawn for reasons of safety or effectiveness. The
petitioner has identified no data or other information suggesting that
VOTRIENT (pazopanib hydrochloride) tablets, 400 mg, were withdrawn for
reasons of safety or effectiveness. We have carefully reviewed our
files for records concerning the withdrawal of VOTRIENT (pazopanib
hydrochloride) tablets, 400 mg, from sale. We have also independently
evaluated relevant literature and data for possible postmarketing
adverse events. We have found no information that would indicate that
this drug product was withdrawn from sale for reasons of safety or
effectiveness.
    Accordingly, the Agency will continue to list VOTRIENT (pazopanib
hydrochloride) tablets, 400 mg, in the ``Discontinued Drug Product
List'' section of the Orange Book. The ``Discontinued Drug Product
List'' delineates, among other items, drug products that have been
discontinued from marketing for reasons other than safety or
effectiveness. ANDAs that refer to VOTRIENT (pazopanib hydrochloride)
tablets, 400 mg, may be approved by the Agency as long as they meet all
other legal and regulatory requirements for the approval of ANDAs. If
FDA determines that labeling for this drug product should be revised to
meet current standards, the Agency will advise ANDA applicants to
submit such labeling.

    Dated: July 29, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-16692 Filed 8-4-21; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 78, Number 131 (Tuesday, July 9, 2013)]
[Notices]
[Page 41073]
[FR Doc No: 2013-16466]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-3351-EM; Docket ID FEMA-2013-0001]

New York; Amendment No. 3 to Notice of an Emergency Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of an emergency declaration for
State of New York (FEMA-3351-EM), dated October 28, 2012, and related
determinations.

DATES: Effective Date: June 24, 2013.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW.,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The Federal Emergency Management Agency
(FEMA) hereby gives notice that pursuant to the authority vested in the
Administrator, under Executive Order 12148, as amended, Willie G. Nunn,
of FEMA is appointed to act as the Federal Coordinating Officer for
this emergency.
    This action terminates the appointment of Michael F. Byrne as
Federal Coordinating Officer for this emergency.

(The following Catalog of Federal Domestic Assistance Numbers (CFDA)
are to be used for reporting and drawing funds: 97.030, Community
Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034, Disaster Unemployment
Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048,
Disaster Housing Assistance to Individuals and Households in
Presidentially Declared Disaster Areas; 97.049, Presidentially
Declared Disaster Assistance--Disaster Housing Operations for
Individuals and Households; 97.050, Presidentially Declared Disaster
Assistance to Individuals and Households--Other Needs; 97.036,
Disaster Grants--Public Assistance (Presidentially Declared
Disasters); 97.039, Hazard Mitigation Grant.)

W. Craig Fugate,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2013-16466 Filed 7-8-13; 8:45 am]
BILLING CODE 9111-23-P